Effect of Unani Palliative Care in cancer

Impact of Unani Palliative Care through modulation in Asbab- e- sita zaroriya (the six essential factors) among the patients of Cancer undergoing treatment (chemotherapy and/or radiotherapy) - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066586

Enrollment

Registered

2024-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C801- Malignant (primary) neoplasm, unspecified

Interventions

Intervention1: Hab e papita 2 tab each of 500mg BD Aujaiya 2 tab each of 500mg BD Rogan e Banafsha Qs for LA HS: Hab e papita for anorexia Aujaiya for musculoskeletal pains Rogan e Banafsha for Insom

Eligibility

Inclusion criteria

Inclusion criteria: clinically and histopathologically diagnosed cancer patients Both Genders Patients who have agreed to sign informed consent and follow up the protocol. Patients attending the JNMC hospital.

Exclusion criteria

Exclusion criteria: Pregnancy and lactations. Cases other than cancer. Patients who are not ready to sign informed consent and follow up the protocol.

Design outcomes

Primary

Measure	Time frame
symptoms relivedTimepoint: 15 days follow up	—

Secondary

Measure	Time frame
quality of life improvedTimepoint: 6 months	—

Countries

India

Contacts

Public ContactAbdul Aziz Khan

Ajmal khan tibbiya College AMU

abdulaziznium@gmail.com9760893505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026